At the center of deployment is mlHealth360’s proprietary Scaida AI platform, designed to detect and triage abnormalities in CT scans
The new device promises faster, more efficient cardiac procedures while maintaining the safety and effectiveness clinicians expect
Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules
The center combines rigorous scientific instruction with practical, hands-on training, equipping providers with the clinical, consultative, and business skills needed to deliver safe, effective, and patient-centered care
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
Collaboration to study integration of AI-enabled VR solutions into medical and nursing curricula
Hands-on clinical workshop in Bengaluru brings together neurologists, ENT specialists and physicians
Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship
The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities
The initiative will be led by David Baker, 2024 Nobel Prize winner in Chemistry, IPD director, professor of biochemistry, and HHMI Investigator at the University of Washington
Subscribe To Our Newsletter & Stay Updated
